New York Blood Center
New findings in SARS vaccines described
Published in Aging and Elder Health Week, February 13th, 2005
Study 1: A receptor-binding domain of the SARS-CoV spike protein induces highly potent neutralizing antibodies.
According to recent research published in the journal Biochemical and Biophysical Research Communications, "The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (CoV), a type I transmembrane envelope glycoprotein, consists of S1 and S2 domains responsible for virus binding and fusion, respectively. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
More Articles from Aging and Elder Health Week
- Allon Therapeutics, Inc.
U.S. FDA approval granted to begin phase I trials of Alzheimer therapy - Alnylam Pharmaceuticals, Inc.
Pharmaceutical firm initiates program for respiratory syncytial virus infection - Ankara Numune Educ. and Research Hosp.
Calcitriol therapy boosts calcium absorption, may affect bone metabolism - BioSante Pharmaceuticals, Inc.
Enrollment completed for Phase III clinical trial for estrogen gel - Bruckner Group
Biotechnology drug revenues will be hard hit by strict benefit management - Center for Clinical & Basic Res., Ballerup
Estrogen therapy regimens have beneficial effect on cartilage - More from this issue of Aging and Elder Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
